Human Genome Epidemiology Literature Finder
|
Records 1 - 12 (of 12 Records) |
| Query Trace: Anemia and NRAS[original query] |
|---|
| A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia. Haematologica 2007 Jun 92 (6): 744-52. Bacher Ulrike, Haferlach Torsten, Kern Wolfgang, Haferlach Claudia, Schnittger Susan |
| Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias. BMC cancer 2010 10 (1): 401. Rocquain Julien, Carbuccia Nadine, Trouplin Virginie, Raynaud Stéphane, Murati Anne, Nezri Meyer, Tadrist Zoulika, Olschwang Sylviane, Vey Norbert, Birnbaum Daniel, Gelsi-Boyer Véronique, Mozziconacci Marie-Joel |
| SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML). Blood 2012 Oct 120 (15): 3080-8. Meggendorfer Manja, Roller Andreas, Haferlach Torsten, Eder Christiane, Dicker Frank, Grossmann Vera, Kohlmann Alexander, Alpermann Tamara, Yoshida Kenichi, Ogawa Seishi, Koeffler H Phillip, Kern Wolfgang, Haferlach Claudia, Schnittger Susan |
| Prognostic score including gene mutations in chronic myelomonocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Jul 31 (19): 2428-36. Itzykson Raphaël, Kosmider Olivier, Renneville Aline, Gelsi-Boyer Véronique, Meggendorfer Manja, Morabito Margot, Berthon Céline, Adès Lionel, Fenaux Pierre, Beyne-Rauzy Odile, Vey Norbert, Braun Thorsten, Haferlach Torsten, Dreyfus François, Cross Nicholas C P, Preudhomme Claude, Bernard Olivier A, Fontenay Michaela, Vainchenker William, Schnittger Susanne, Birnbaum Daniel, Droin Nathalie, Solary Er |
| Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutation. European journal of haematology 2015 Mar . Peng Jie, Zuo Zhuang, Fu Bin, Oki Yasuhiro, Tang Guilin, Goswami Maitrayee, Priyanka Priyanka, Muzzafar Tariq, Medeiros L Jeffrey, Luthra Rajyalakshmi, Wang Sa |
| Efficacy of azacitidine is independent of molecular and clinical characteristics - an analysis of 128 patients with myelodysplastic syndromes or acute myeloid leukemia and a review of the literature. Oncotarget 2018 Jun 9 (45): 27882-27894. Kuendgen Andrea, Müller-Thomas Catharina, Lauseker Michael, Haferlach Torsten, Urbaniak Petra, Schroeder Thomas, Brings Carolin, Wulfert Michael, Meggendorfer Manja, Hildebrandt Barbara, Betz Beate, Royer-Pokora Brigitte, Gattermann Norbert, Haas Rainer, Germing Ulrich, Götze Katharina |
| TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. Leukemia 2019 Jan . Haase Detlef, Stevenson Kristen E, Neuberg Donna, Maciejewski Jaroslaw P, Nazha Aziz, Sekeres Mikkael A, Ebert Benjamin L, Garcia-Manero Guillermo, Haferlach Claudia, Haferlach Torsten, Kern Wolfgang, Ogawa Seishi, Nagata Yasunobu, Yoshida Kenichi, Graubert Timothy A, Walter Matthew J, List Alan F, Komrokji Rami S, Padron Eric, Sallman David, Papaemmanuil Elli, Campbell Peter J, Savona Michael R, Seegmiller Adam, Adès Lionel, Fenaux Pierre, Shih Lee-Yung, Bowen David, Groves Michael J, Tauro Sudhir, Fontenay Michaela, Kosmider Olivier, Bar-Natan Michal, Steensma David, Stone Richard, Heuser Michael, Thol Felicitas, Cazzola Mario, Malcovati Luca, Karsan Aly, Ganster Christina, Hellström-Lindberg Eva, Boultwood Jacqueline, Pellagatti Andrea, Santini Valeria, Quek Lynn, Vyas Paresh, Tüchler Heinz, Greenberg Peter L, Bejar Rafael, |
| Venetoclax plus azacitidine and donor lymphocyte infusion in treating acute myeloid leukemia patients who relapse after allogeneic hematopoietic stem cell transplantation. Annals of hematology 2021 Sep . Zhao Peng, Ni Ming, Ma Dan, Fang Qin, Zhang Yan, Li Yanju, Huang Yi, Chen Ying, Chai Xiao, Zhan Yun, Li Yan, Kang Qian, Zhao Mei, Liu Min, Zhang Fengqi, Huang Shisi, Wen Shuangshuang, Deng Bo, Wang Jis |
| Prediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data. Scientific reports 2021 7 11 (1): 14321. Fernández Montes Ana, Carmona-Bayonas Alberto, Jimenez-Fonseca Paula, Vázquez Rivera Francisca, Martinez Lago Nieves, Covela Rúa Marta, Cousillas Castiñeiras Antía, Gonzalez Villarroel Paula, De la Cámara Gómez Juan, Méndez José Carlos Méndez, Carriles Fernández Carmen, Sanchez Cánovas Manuel, Garcia García Tere |
| [Mutational Spectrum and Prognosis Analysis of AML Patients Based on High-Throughput Sequencing]. Zhongguo shi yan xue ye xue za zhi 2021 Apr 29 (2): 353-362. Li Jian-Xiong, Liu Heng, Sheng Hong-Xia, Zhang B |
| Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 3 28 (14): 3002-3010. Schuler Martin, Zimmer Lisa, Kim Kevin B, Sosman Jeffrey A, Ascierto Paolo A, Postow Michael A, De Vos Filip Y F L, van Herpen Carla M L, Carlino Matteo S, Johnson Douglas B, Berking Carola, Reddy Micaela B, Harney Allison S, Berlin Jordan D, Amaria Rodabe |
| Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. JCO precision oncology 2022 11 6 e2200191. Klute Kelsey A, Rothe Michael, Garrett-Mayer Elizabeth, Mangat Pam K, Nazemzadeh Reza, Yost Kathleen J, Duvivier Herbert L, Ahn Eugene R, Cannon Timothy L, Alese Olatunji B, Krauss John C, Thota Ramya, Calfa Carmen J, Denlinger Crystal S, O'Lone Raegan, Halabi Susan, Grantham Gina N, Schilsky Richard |
- Page last reviewed:Feb 1, 2024
- Content source: